A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors

The use of monoclonal antibodies (mAb) for the diagnosis and treatment of malignancies is acquiring an increasing clinical importance, thanks to their specificity, efficacy and relative easiness of use. However, in the context of Epstein-Barr virus (EBV)-related malignancies, only cancers of B-cell...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Turrini, Riccardo, Merlo, Anna, Martorelli, Debora, Faè, Damiana Antonia, Sommaggio, Roberta, Montagner, Isabella Monia, Barbieri, Vito, Marin, Oriano, Zanovello, Paola, Dolcetti, Riccardo, Rosato, Antonio
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414862/
https://ncbi.nlm.nih.gov/pubmed/28507812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1304338
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars